Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Methane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL29598993 | 0.82 | — | — | |
| Water SCHEMBL19761 | 0.82 | — | — | |
| Water SCHEMBL28099857 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL2511426 | 0.67 | — | — | |
| Methane SCHEMBL3211016 | 0.67 | — | — | |
| Methane SCHEMBL23273758 | 0.67 | — | — | |
| Methane SCHEMBL5074978 | 0.67 | — | — | |
| Charcoal, Activated SCHEMBL3020901 | 0.67 | — | — | |
| Water SCHEMBL8750572 | 0.67 | — | — | |
| Water SCHEMBL23929194 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012059797-A1 | PROCESS FOR SYNTHESIS OF (S) - PREGABALIN | LUPIN LIMITED (IN) | 2012-05-10 | — | — | WO | claimed |
| CN-117580824-A | Modulators of integrated stress pathways | 卡里科生命科学有限责任公司 | 2024-02-20 | — | — | CN | disclosed |
| US-20230293522-A1 | HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-09-21 | — | — | US | disclosed |
| CN-116332873-A | Protein tyrosine phosphatase inhibitors and methods of use thereof | 卡里科生命科学有限责任公司 | 2023-06-27 | — | — | CN | disclosed |
| WO-2022255416-A1 | METHOD FOR PRODUCING CATECHIN CONJUGATE | 花王株式会社 | 2022-12-08 | — | — | WO | disclosed |
| WO-2022255417-A1 | METHOD FOR PRODUCING CATECHIN CONJUGATE | 花王株式会社 | 2022-12-08 | — | — | WO | disclosed |
| CN-115298171-A | Method for producing epigallocatechin gallate conjugate | 花王株式会社 | 2022-11-04 | — | — | CN | disclosed |
| EP-3901159-A1 | HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME | Millennium Pharmaceuticals, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3517112-B1 | HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME | MILLENNIUM PHARM INC (US) | 2021-04-07 | — | — | EP | disclosed |
| US-10780090-B2 | Heteroaryl compounds useful as inhibitors of SUMO activating enzyme | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2020-09-22 | — | — | US | disclosed |
| EP-2384328-A1 | 6,7,8,9-TETRAHYDRO-5H-1,4,7,10A-TETRAAZA-CYCLOHEPT[F]INDENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR PREPARING THEM | Boehringer Ingelheim International GmbH (DE) | 2011-11-09 | — | — | EP | disclosed |
| CN-101395154-B | 8-azabicyclo [3.2.1] octane compounds as mu opioid receptor antagonists | THERAVANCE INC | 2011-01-19 | — | — | CN | disclosed |
| WO-2010060952-A1 | 6,7,8,9-TETRAHYDRO-5H-1,4,7,10A-TETRAAZA-CYCLOHEPT[F]INDENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-06-03 | — | — | WO | disclosed |
| CN-101395154-A | 8-azabicyclo [3.2.1] octane compounds as mu opioid receptor antagonists | THERAVANCE INC (US) | 2009-03-25 | — | — | CN | disclosed |
| CN-101198604-A | NPY antagonists, their preparation and use | CEREP (FR) | 2008-06-11 | — | — | CN | disclosed |
| CN-1898238-A | Oxazolidinone-quinolone hybrid antibiotics | MORPHOCHEM AG FUER KOM (DE) | 2007-01-17 | — | — | CN | disclosed |
| CN-1729192-A | Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors | PFIZER PROD INC (US) | 2006-02-01 | — | — | CN | disclosed |
| CN-1130365-C | Alpha-1 adrenergic compounds, pharmaceutical compositions containing the same and uses thereof | ABBOTT CO (US) | 2003-12-10 | — | — | CN | disclosed |
| CN-1425026-A | Cyclic hexapeptide derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-06-18 | — | — | CN | disclosed |
| CN-1246861-A | Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds | ABBOTT LAB (US) | 2000-03-08 | — | — | CN | disclosed |